Dublin, Sept. 02, 2022 (GLOBE NEWSWIRE) -- The "Global Superdisintegrants Market (2022-2027) by Type, Formulation, Therapeutic Area, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering. The Global Superdisintegrants Market is estimated to be USD 461.14 Mn in 2022 and is projected to reach USD 662.03 Mn by 2027, growing at a CAGR of 7.5%. Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the Global Superdisintegrants Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals. As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Anshul Life Sciences, Ashland Global Specialty Chemicals, BASF, etc. Countries Studied

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc. Ansoff Analysis

Key Topics Covered: 1 Report Description 2 Research Methodology 3 Executive Summary 4 Market Dynamics 4.1 Drivers 4.1.1 Increase in Consumption of Orally Disintegrating Tablets and Capsules 4.1.2 Growing Adoption of the Generic Drugs 4.2 Restraints 4.2.1 High Manufacturing Cost 4.2.2 4.3 Opportunities 4.3.1 Development of New Superdisintegrants for the Pharmaceutical Industry 4.3.2 Acceptance of Natural Superdisintegrants 4.4 Challenges 4.4.1 Safety and Quality Concerns 5 Market Analysis 5.1 Regulatory Scenario 5.2 Porter's Five Forces Analysis 5.3 Impact of COVID-19 5.4 Ansoff Matrix Analysis 6 Global Superdisintegrants Market, By Type 6.1 Introduction 6.2 Synthetic Superdisintegrants 6.2.1 Crospovidone 6.2.2 Modified Starch (Sodium Starch Glycolate) 6.2.3 Modified Cellulose 6.2.3.1 Croscarmellose Sodium 6.2.3.2 Low-Substituted Hydroxypropyl Cellulose 6.2.4 Calcium Silicates 6.2.5 Ion Exchange Resins 6.3 Natural Superdisintegrants 6.4 Other Superdisintegrants 7 Global Superdisintegrants Market, By Formulation 7.1 Introduction 7.2 Tablets 7.3 Capsules 8 Global Superdisintegrants Market, By Therapeutic Area 8.1 Introduction 8.2 Neurological Diseases 8.3 Gastrointestinal Diseases 8.4 Oncology 8.5 Inflammatory Diseases 8.6 Infectious Diseases 8.7 Cardiovascular Diseases 8.8 Hematological Diseases 9 Americas' Superdisintegrants Market 9.1 Introduction 9.2 Argentina 9.3 Brazil 9.4 Canada 9.5 Chile 9.6 Colombia 9.7 Mexico 9.8 Peru 9.9 United States 9.10 Rest of Americas 10 Europe's Superdisintegrants Market 10.1 Introduction 10.2 Austria 10.3 Belgium 10.4 Denmark 10.5 Finland 10.6 France 10.7 Germany 10.8 Italy 10.9 Netherlands 10.10 Norway 10.11 Poland 10.12 Russia 10.13 Spain 10.14 Sweden 10.15 Switzerland 10.16 United Kingdom 10.17 Rest of Europe 11 Middle East and Africa's Superdisintegrants Market 11.1 Introduction 11.2 Egypt 11.3 Israel 11.4 Qatar 11.5 Saudi Arabia 11.6 South Africa 11.7 United Arab Emirates 11.8 Rest of MEA 12 APAC's Superdisintegrants Market 12.1 Introduction 12.2 Australia 12.3 Bangladesh 12.4 China 12.5 India 12.6 Indonesia 12.7 Japan 12.8 Malaysia 12.9 Philippines 12.10 Singapore 12.11 South Korea 12.12 Sri Lanka 12.13 Thailand 12.14 Taiwan 12.15 Rest of Asia-Pacific 13 Competitive Landscape 13.1 Competitive Quadrant 13.2 Market Share Analysis 13.3 Strategic Initiatives 13.3.1 M&A and Investments 13.3.2 Partnerships and Collaborations 13.3.3 Product Developments and Improvements 14 Company Profiles 14.1 Anshul Life Sciences 14.2 Ashland Global Specialty Chemicals 14.3 BASF 14.4 Corel Pharma Chem 14.5 DFE Pharma 14.6 Dow Chemicals 14.7 DuPont 14.8 Gangwal Chemicals 14.9 JRS Pharma 14.10 Merck 14.11 Nippon Soda 14.12 Nitika Pharmaceutical Specialities 14.13 Roquette Freres 14.14 Shanghai Welltone Material Technology 14.15 Sigachi Industries 15 Appendix For more information about this report visit https://www.researchandmarkets.com/r/f0s4qd

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.